Spatial expression pattern of proBcMF26a: GUS-GFP. by Meiling Lyu (767333)

“…<p>(A–L) Histochemical GUS assays of the T₂<i>Arabidopsis</i> transformed with pBGWFS7.0–proBcMF26a: GUS-GFP vector. …”

Figure 5 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma by Yichi Zhang (20458547)

“…Values are means ± SD (<i>n</i> = 5 experimental points, **, <i>P</i> < 0.01). FAK-WT values set to 1 (dotted line).…”

Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

A novel SNP of <i>MYO1A</i> gene associated with heat-tolerance in Chinese cattle by Yanhong Cao (428443)

RSV-induced Remodeling of cytoskeletal proteins. by Terri J. Harford (3726478)

Met inhibits RANKL-induced AMPK, NF-κB and ERK activation during osteoclastogenesis. by Haohui Guo (6516638)

CCR2 deficiency elevates <i>C</i>. <i>muridarum</i>-induced Th17-type immune response. by Shuaini Yang (20670608)

Schematic representation showing different phases and outcomes of stochastic bubbles for (4) with <i>b</i> = 0.42, <i>g</i> = −0.04, <i>σ</i>_<i>x</i> = 0.6, <i>σ</i><sub... by Damian Smug (5040890)

“…<b>(A)</b> and <b>(B)</b> Foreshocks {1/2} and {3/4} preceding the main crash {5/6} are clearly visible. The time intervals between the consecutive local peaks and corrections decrease as a result of at least two factors: first, until around <i>z</i> = 0.2, the price <i>x</i> accelerates making it prone to take a time consuming detour for smaller <i>x</i> {2} that becomes less impactful compared to when <i>x</i> is larger {4}. …”

Sequence analysis of <i>GsCML27</i>. by Chao Chen (195669)

CCR2 deficiency attenuates the infiltration of myeloid cells and diminishes the numbers and activation of T cells following <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

Th1 differentiation and IFN-γ secretion are impaired in <i>ccr2</i>^-/- mice during <i>C</i>. <i>muridarum</i> infection. by Shuaini Yang (20670608)

Reduced resistance and exacerbated lung inflammation in <i>ccr2</i>^-/- mice with <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

CD4⁺CD25^hiFOXP3⁺ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel by Yvonne Schmiedel (785554)

“…Cytokines responses (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) were integrated using Principal Component Analysis (PCA). …”